Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks

NCT04410965 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
82
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi